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SulTlnlary 
Signals through the B cell antigen receptor lead to a variety of cellular events such as activation, 
anergy, and apoptosis. B cells select these outcomes to establish and maintain self-tolerance, and 
to mount adequate antibody responses.  However, it is not fully understood how one and the 
same signal causes such different consequences. In the present study, we have studied the effect 
of activation  signals  on the  outcome of responses  to  antigen  receptor ligation.  Two  distinct 
growth-promoting signals were used to activate B cells.  Ligation of either ILP105, a newly dis- 
covered B  cell surface molecule, or the CD40 molecule, drove B cells to proliferate. Resultant 
blastic  cells  were  then  exposed  to  anti-immunoglobulin  M  (IgM).  Blast  cells  that  had been 
stimulated  with  anti-R.P105  ceased  growing and  underwent  apoptosis  after  cross-linking  of 
surface  IgM.  Coligation  of the  Fc~/ receptor  liB  with  surface  IgM  augmented,  rather  than 
aborted, this response. In contrast to R.P105-activated B cells, blast cells that had been activated 
by CD40 ligation were unaltered by anti-IgM. On the other hand, CD40-activated B  cells be- 
came extremely susceptible  to Fas-mediated apoptosis, whereas RP105-activated B  cells  were 
much less sensitive. Anti-IgM-induced apoptosis in ILP105 blasts was independent of Fas, be- 
cause it was demonstrable with Fas-deficient MRL-Ipr/lpr mice. These results demonstrate that 
the nature of an initial activation signal has a great influence on the fate of activated B cells after 
(re)engagement  of the  antigen  receptor.  RP105,  as well  as  CD40,  may be important  in this 
life/death decision. 
S 
ignals through the B cell antigen receptor do not always 
lead to activation. They also result in anergy or apopto- 
sis under certain circumstances  (for a review see reference 
1). Anergy and apoptosis have been implicated in establish- 
ing self-tolerance  in immature  B  cells,  whereas  activation 
occurs in mature B cells.  However, mature B cells may also 
have to undergo apoptosis in response to antigens during or 
at the terminating stage of immune responses. During affin- 
ity maturation  in the  germinal  center,  some  of the  newly 
emerged specificities may correspond to self-antigens. Also, 
excessive numbers of activated B cells have to be deleted to 
prevent  an excessive response  or to terminate  an immune 
response, as is the case with T  cells (for a reviews see refer- 
ences  2  and  3).  It  has  been  recently  demonstrated  that  a 
large amount of soluble antigen, identical to that used for im- 
munization,  delivers an apoptotic signal to antigen-specific 
germinal  center B  cells  when  administered  at  the  peak of 
the  response  (4--6).  These  models  demonstrate  that  anti- 
gen-induced cell death occurs in mature B  cells.  However, 
it  is  not  yet  understood  how  these  two  opposite  conse- 
quences,  activation  and  apoptosis,  are  regulated  by  the 
same antigenic signal. 
We  have  recently identified  a  cell surface  molecule  re- 
ferred to as R.P105  that is expressed on mature B  cells  but 
not on pre-B or T  cells  (7).  The 1LP105 protein is mono- 
meric,  105  kD  in size,  and a  member  of the  leucine-rich 
repeat protein family (8).  Tandem repeats of a leucine-rich 
motif in  the  extracellular  portion  are  thought  to  be  in- 
volved in processes such as cell adhesion or receptor-ligand 
interactions.  An  antibody  against  ILP105  protects  B  cells 
from apoptosis  induced  by irradiation  or  dexamethasone, 
and  drives  them  to proliferate  (7).  Therefore,  the  kP105 
molecule transmits an activation signal that protects B  cells 
from some types ofapoptosis. 
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by tLP105 ligation is dramatically affected by cross-linking 
of surface IgM (slgM) 1, and is different in this respect from 
CD40-dependent B  cell activation. CD40-activated B  cells 
were  induced to  die via the  Fas antigen as previously re- 
ported  (9-11),  but  not  via  antigen receptor  ligation.  In 
contrast, growth of RP105-activated B  cells was  arrested; 
the  cells  died  by  apoptosis  in a  Fas  antigen-independent 
manner upon  exposure  to  anti-IgM.  KP105-activated B 
cells  also  showed  responsiveness to  Fas ligation, but to  a 
lesser degree than CD40-activated B  cells. Thus, these two 
growth-promoting signals lead to different outcomes after 
engagement ofslgM. We also describe a positive regulatory 
effect  of the  Fo/  receptor  IIB  (Fc'yILIIB)  on  anti-IgM- 
induced growth arrest and cell death of activated B cells. 
Materials and Methods 
Mice.  BALB/c,  MKL/MpJ-+/+(MRL-+/+),  and MR.L/ 
MpJ-lpr/lpr (MRL-lpr/lpr)  mice were purchased  from Japan SLC 
Co.  (Hamamatsu, Japan)  and used at 6-8 wk of age. All experi- 
ments were carried out according to the guidelines at Saga Medi- 
cal School for the Care and Treatment of Laboratory Animals. 
Abs.  Kat anti-mouse mAbs against KPI05 (KP/14 or RP/ 
16) and IgM (AM/3) were established in our laboratory,  and de- 
scribed previously (7). Hamster anti-Fas mAb (Jo2, IgG) (12) and 
rat anti-mouse CD40 mAb (LB429, IgG2a/K)  (13) were also pre- 
viously reported. We also used another anti-CD40 mAb (HM40-3; 
hamster IgM)  (14), that gave similar results to LB429.  Rat anti- 
mouse CD45IL/B220  antibody, RA3-6B2,  was  obtained from 
Dr. Shinya Murakami (Osaka University Medical School,  Osaka, 
Japan).  Rat  anti-mouse Fc~/RIIB,  2.4G2  was  purchased  from 
PharMingen (San Diego, CA). Intact and F(ab')2 fragments of af- 
finity-purified rabbit  anti-mouse IgM  (Ix-chain  specific) were 
purchased  from Zymed Laboratories,  Inc. (South  San Francisco, 
CA). These anti-IgM Abs were able to activate freshly prepared 
B cells. It is known that intact rabbit anti-IgM coligates Fo/R.IIB 
and hardly activates B cells (see Table 1). Blocking the FcytLIIB 
with  an  antibody allowed  the  response  to  proceed  (data not 
shown). As expected,  F(ab')a fragments  of rabbit anti-IgM acti- 
vated splenic B cells in the absence  of anti-Fo/RIIB (see Table 
1). These two anti-IgM Abs allowed us to see an effect of engage- 
ment of slgM with or without coligation of the  Fc~ILIIB.  For 
subdiploid DNA analysis, we also used goat anti-IgM Abs  (see 
Fig.  1 A).  Intact and  F(ab')2  fragments  were  purchased  from 
Zymed Laboratories,  Inc. and Organon Teknika Co.  (Durham, 
NC), respectively. 
Enrichment of B Cells  fiom the Spleen.  B cells were enriched by 
a panning technique. Plastic dishes were coated with 10 Ixg/ml 
mouse anti-rat K mAb (MAIL18.5; obtained from American Type 
Culture Collection, Rockville, MD) in HBSS at room tempera- 
ture for 2 h. After washing with HBSS, mixtures of culture super- 
natant containing rat mAb against mouse CD4 (GK1.5;  15) and 
mouse CD8 (LICtL.LAU.RL172/4; 16) were added to the anti- 
rat K-coated  dishes and incubated for 2 h  at room temperature. 
After washing out unbound mAbs, spleen cells were added to the 
dishes and incubated for 1 h at 4~  The unbound cells were col- 
lected and used as splenic B cells. 
1Abbreviations used in this paper: Fc34~IIB, Fo/ receptor liB, slgM, sur- 
face IgM. 
Cell Proliferation Assay.  Splenic  B  cells (5  X  106  cells/well) 
were inoculated into a 6-well plate  (Costar  Corp.,  Cambridge, 
MA)  and cultured with  anti-RP105  (5  Ixg/ml)  or  anti-CD40 
mAb (10 Ixg/ml) for 48 h. These two antibodies were used at op- 
timal concentrations for inducing B cell proliferation.  Cells were 
washed twice and cultured again in a 96-well plate (Becton Dick- 
inson Labware, Lincoln Park, NJ) at 2 X 105 cells/well with indi- 
cated antibodies for 48 h. The cultures were pulsed with 1 IxCi of 
[3H]TdR.  (ICN R.adiochemicals,  Irvine, CA)  for the  final 4  h. 
They were then harvested onto glass fiber filters and the incorpo- 
rated radioactivity  was determined on a Beta plate flat-bed liquid 
scintillation counter (Pharmacia-Wallac,  Gaithersbnrg,  MD). The 
results are presented as means •  SD of triplicate wells. 
Measurement of DNA Content.  Splenic  B  cells were  cultured 
with KP105 or CD40 mAb for 48  h  as described  above.  Cells 
were harvested  and viable cells were obtained by removing dead 
cells using density gradient centrifugation with Lympholyte-M 
(Cedarlane  Laboratories  Ltd.,  Ontario, Canada).  Cells were then 
cultured again with the indicated antibodies for 24 or 48 h. Cells 
were harvested  and cell cycle analysis was carried  out with the 
CycleTEST  TM  Plus DNA reagent kit (Becton Dickinson Immu- 
nocytometry Systems, San Jose,  CA). For determining percent- 
ages of cell with subdiploid DNA, harvested  cells were fixed  in 
70% ethanol, and stained with PBS containing 50 Ixg/ml propid- 
ium iodide (Sigma Chemical Co., St. Louis, MO) and 10 Ixg/ml 
RNase (Nippon Gene, Toyama, Japan).  Cells were analyzed on a 
FACScan  |  (Becton Dickinson & Co., Mountain View, CA). 
Immunofluorescence Analysis.  Cells in suspension (5  X 105 cells/ 
200 Ixl) were incubated for 20 min on ice with anti-Fas. After two 
washes, FITC-labeled protein A (Zymed Laboratories,  Inc.) was 
used as the second reagent.  Propidium iodide was included dur- 
ing this incubation period and used as a gating parameter to ex- 
clude dead cells. Labeled cells were then analyzed on a FACScan  | 
(Becton Dickinson & Co.). 
Wright Giemsa Staining.  Harvested  cells were cytocentrifuged 
for 4 rain at 400 rpm on slides (Shandon, Sewickley,  PA). After 
Table 1.  Inhibition of RPlO5-dependent B Cell Growth by 
Simultaneous Addition  of Anti-IgM Abs 
[3H]TdK uptake 
Ab added  Without anti-P.P105  With anti-R.P105 
gpm 
None  281  _+ 31  68,956  +  528 
Control Ab  636 •  86  62,137  -  3,360 
Monoclonal anti-IgM  282  -+ 12  2,785  +  338 
Intact anti-IgM  206  +  34  5,130  +  115 
F(ab') anti-IgM  3,470  _+  163  33,624  +  200 
Anti-Fas  647 +  49  62,847  +  1,083 
Splenic B cells were cultured with the indicated antibodies for 2 d. 
Anti-CD45[L/B220 was used as a control Ab. Kabbit antibodies were 
used as intact and F(ab')2 antibodies. All the antibodies were used at 
a concentration of 10 ~g/ml to achieve maximal effect (see Fig. 1). 
The same amount of antibodies was used in the following experi- 
ments except Fig.  1.  [3H]TdR. was added during the last 4 h of 
the culture. The results are represented as mean +  SD for tripli- 
cate cultures. 
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Pure Chemicals, Ltd., Tokyo, Japan) for 4 min, washed in water, 
and stained again with 10% Giemsa's solution (Muto Pure Chem- 
icals, Ltd.) diluted in PBS for 15 rain. 
Results 
RPlO5-activated  B  Cells Are Sensitive to Anti-IgM-induced 
Growth Inhibition.  Engagement  of RP105  alone  induces 
potent growth of mature B  cells (7).  Interestingly, simulta- 
neous  cross-linking  of surface  IgM  drastically  suppressed 
this-RP105-dependent  proliferation  (Table  1).  It was im- 
portant  to  use  intact  anti-IgM  Ab,  and  F(ab')2  fragments 
were  not  as  effective.  Also,  the  inhibitory  effect was  less 
marked when  B  cells were  first  exposed  to  anti-IgM  fol- 
lowed 1 d later by treatment with anti-RP105  Ab (data not 
shown).  In  contrast,  blast  cells  generated  by  ligation  of 
RP105  for 2 d were extremely sensitive to the antiprolifer- 
ative  effects  of antigen  receptor  cross-linking  (Table  2). 
Thus, the first signal markedly affected a responsiveness to a 
subsequent signal. The balance of our study was focused on 
determining  the  influence  of activation  signals  on  antigen 
receptor signaling. Therefore, we studied the fate of B  cells 
that  had  been  activated  by  ligation  of either  RP105  or 
CD40 and subsequently exposed to anti-IgM. 
Both of these activation signals effectively induced B  cell 
blasts  and  the  activated  cells  were  similar with  respect  to 
the  expression  of  a  number  of  cell  surface  markers 
(CD45R/B220,  IgM, IgD, I-A, I-E, CD23, CD24, CD40, 
and RP105;  data not shown). The resulting blasts were col- 
lected, washed,  and cultured  again with an antibody to ei- 
ther  IgM  or  Fas.  Incorporation  of [3H]TdR  was  then  as- 
sessed 2  d  later.  As was reported  (9-11),  B  cells that were 
responding  to  the  anti-CD40  Ab  (CD40  blasts)  were  ex- 
tremely sensitive to anti-Fas  (Table 2).  Splenic B  cells that 
Table 2.  Sensitivity  orB Cell Blasts to Receptor Ligation Depends 
on the Means of Activation 
[3H]TdR uptake 
Ab  RP105 blasts  CD40 blasts 
cpm 
None  45,993  +  4,056  43,651  +  5,826 
ControlAb  48,588  +  1,463  50,971  +  3,794 
Intact anti-IgM  2,758  +  581  56,845  _  4,434 
F(ab')2 anti-IgM  28,512  +  7,801  57,703  +_ 2,695 
Anti-Fas  15,673 +  1,439  1,433  +- 136 
Splenic B cells were cultured with either anti-RP105  (RP105 blasts) or 
anti-CD40  mAb (CD40  blasts). After 2 d of culture,  cells were har- 
vested, washed,  and cultured  again with the indicated antibodies for 
2 d. The numbers  of recovered  cells were 1.6  ￿  106 (RP105  blasts: 
89% recovery)  and 6.5  ￿  10  S (CD40  blasts: 36.1% recovery)  out of 
1.8  ￿  10  6 input cells. Anti-CD45R/B220  was used as a control Ab. 
Rabbit antibodies were used as intact and F(ab')2 antibodies. [3H]TdR 
was added during the last 4 h of the culture. The results are presented as 
means +  SD for triplicate cultures. 
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had been  activated with  anti-RP105  (RP105  blasts)  were 
much less so.  The inhibitory  effect was obvious at a  con- 
centration  of 0.01  I.tg/ml and during  1-5 d  after the  addi- 
tion  of the  antibody  (Figs.  1  and  2).  In  striking  contrast, 
RP105  blasts were sensitive to anti-IgM (Table 2). The in- 
hibition was dose dependent  and most apparent between  1 
and 3  d  after the beginning  of the  culture  (Figs.  1 and  2). 
The inhibition  of proliferation was virtual/y complete with 
intact Ab but less so with F(ab')2 Ab. The growth of CD40 
blasts was not  inhibited  at all by either form of anti-IgM. 
Thus,  the antigen receptor on activated B  cells transmitted 
negative signals when the initial activation signal was deliv- 
ered through RP105  but not CD40. 
Engagement of slgM Leads to  Cell  Cycle Arrest of RPI05 
Blasts and Coligation of the Fc Receptor Augments It.  The  in- 
hibitory effect of anti-IgM  on RP  blasts was further  stud- 
ied.  The  reduction  of [3H]TdR  uptake  could  result  from 
either growth arrest or apoptosis.  Cell  cycle status was as- 
sessed at 24 h  or 48 h  after ligation of the antigen receptor 
on RP105  or CD40  blasts.  At 24  h,  neither form of anti- 
IgM  arrested  cycling  of CD40  blasts  and  similar  results 
were  obtained  at 48  h  (Table  3,  and  data  not  shown).  In 
fact, the number of the  S phase increased in many experi- 
ments with anti-IgM F(ab')2  Ab.  Such an increase was not 
clearly observed with the intact anti-IgM. Coligation of the 
Fc"/RIIB is likely to abort a signal through  slgM.  In sharp 
contrast  to  CD40  blasts,  cell  cycling  of RP105  blasts was 
arrested with either form of anti-IgMs. This time, intact Ab 
was more effective than F(ab')2 Ab. As expected,  cell cycle 
arrest  by  intact  anti-IgM  became  less  pronounced  in  the 
presence  of anti-Fc~RIIB  (data not  shown).  Anti-Fas  had 
no  significant effect on either CD40  or RP105  blasts. We 
conclude from these results that engagement ofslgM arrests 
cycling of RP105  blasts but not CD40 blasts,  and concur- 
rent ligation of the Fc~/RIIB augments the cell cycle arrest. 
B  Cells Activated by Anti-RPl05 Ab  Undergo Apoptosis in 
Response to Anti-IgM.  We  observed few viable and many 
dead  cells in RP105  blasts cultured  with  anti-IgM Ab for 
24  h  as  compared with those  cultured  with  control Ab or 
without  Ab.  This  difference  was  more  marked  when  the 
culture proceeded for another  24 h  (data not shown).  We 
further investigated the fate of RP105 blasts after slgM liga- 
tion, and found evidence for apoptosis (Fig. 3). Percentages 
of cells with subdiploid DNA  increased dramatically when 
RP105  blasts were  exposed to  monoclonal  or intact  anti- 
IgM. Additional  evidence for apoptosis was obtained by an 
increase  in  orthogonal  light  scatter  by  flow  cytometry, 
DNA  fragmentation  assessed from gel electrophoresis,  and 
apoptotic  figure  with  nuclear  condensation  revealed  by 
Giemsa  staining  (Fig.  4).  Inclusion  of anti-Fc~RIIB  par- 
tially reduced  apoptosis induction  by intact fragments (data 
not shown).  There was a smaller but consistent increase in 
apoptotic  cells  after  addition  of anti-IgM  F(ab')2  as  com- 
pared  with  the  intact  Ab  (Fig.  3).  These  results  contrast 
with  those  obtained  from  CD40  blasts  that  were  com- 
pletely resistant  to both forms of anti-IgM Abs.  With  re- 
gard to Fas-mediated apoptosis, although CD40 blasts were 
much more sensitive, RP105  blasts showed less but consis- A. RP105 blasts  B. CD40 blasts 
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Figure  1.  Inhibition  of  RP105  and/or 
CD40 blasts with an antibody to surface  lgM 
or Fas (dose dependence). RPI05 and CD40 
blasts were prepared as in Table  2,  and  cul- 
tured  with  indicated  antibodies  at  varying 
concentrations. Anti-CD44 mAb was used as 
a control mAb (A). Two anti-IgM antibodies 
were  used,  a  monoclonal  anti-lgM  (AM/3; 
O) and the intact fragment of rabbit anti-IgM 
(I-1). Jo2  was  used  as  an  anti-Fas  Ab  (O)- 
[3H]TdR was added during the last 4 h of the 
culture. Each plot represents the mean of trip- 
licate cultures and is shown as a percentage of 
the  control response that  did  not include  an 
antibody.  Rabbit  anti-lgM  F(ab')2  reached 
the maximal inhibition at  3-5  p.g/ml, as did 
the intact antibody (data not shown). 
tent  responsiveness  (Fig.  3  A).  We  conclude  that  RP105 
but not CD40 blasts undergo  apoptosis when surface anti- 
gen  receptors  are engaged,  and  coligation  of the  Fc~/RIIB 
enhances induction  of apoptosis. 
Fas  Is  Not  Required for  Receptor-mediated Apoptosis of 
RPlOS-stimulatecl B Cell Blasts.  Previous  studies  of T  cell 
blasts  demonstrated  an  essential  role  of the  Fas antigen  in 
TCR-mediated  apoptosis  (17-19).  We  found  that RP105 
blasts differ from CD40 blasts in the amount of the Fas an- 
tigen  expression  (Fig.  5).  RP105  blasts  were  similar  to 
freshly  isolated  B  cells  in  this  respect.  However,  this  was 
sufficient for some Fas-mediated cell death (Fig. 3). There- 
fore we employed  Fas-deficient MRL-Ipr/lpr mice  (20)  to 
ask whether slgM-triggered  cell death required  Fas.  In re- 
sponse  to  engagement  of RP105  or  CD40,  B  cells  from 
MRL-Ipr/Ipr  mice  showed  comparable  proliferation  to 
wild-type mice (data not shown).  The Fas antigen was not 
detected  on either blast cells or normal spleen  cells of ho- 
mozygous  defective  mice  (data  not  shown).  RP105  and 
CD40 blasts from MRL-lpr/lpr mice were then exposed to 
anti-IgM  or anti-Fas,  and  DNA  content  of blast cells was 
examined (Table 4). As expected,  monoclonal anti-Fas had 
no  effect on  either blasts.  Nevertheless,  RP105  blasts  un- 
derwent apoptosis in response to anti-IgM Abs. From these 
results, we conclude that an anti-IgM-induced B cell apop- 
tosis is not Fas mediated. 
Discussion 
One of the most important questions about B  cell recep- 
tor signaling is how the same stimulus leads to quite differ- 
ent  consequences  that  include  activation,  growth  arrest, 
and cell death.  It has been demonstrated  that, whereas im- 
mature B cells easily undergo apoptosis after engagement of 
slgM,  mature B  cells do not  (21).  We confirmed the latter 
finding by examining the DNA  content  of splenic mature 
B  cells that had been cultured  for 24  h  with anti-IgM Abs 
(Yamashita,  Y.,  K.  Miyake,  and  M.  Kimoto,  unpublished 
observations). Mature resting B  cells seem to have no alter- 
native but activation in response to slgM ligation. After ac- 
tivation by CD40 engagement, B  cells remained resistant to 
anti-IgM-induced  apoptosis  (Fig.  3),  and  cell  cycling was 
accelerated by anti-IgM F(ab')2 (Table 3). In sharp contrast, 
RP105-mediated  activation  opened  a  pathway  to  anti- 
IgM-induced growth arrest and apoptosis (Table 3 and Fig. 
3).  Thus,  mature B  cells still retain  a  choice to arrest their 
growth and die in response to slgM engagement,  and acti- 
vation  signals  have  a  great influence  on  this  type  of life/ 
death decision. 
Because  normal heterogeneous  B  cells were used in  the 
present study,  it is possible that RP105  ligation  selectively 
activated  a  very  minor  population  of splenic  B  cells  that 
were susceptible to anti-IgM-induced  death before activa- 
tion. However, most mature B cells express RP105,  and al- 
80000  30000 
60000- 
~.  40000 
rr"  "ID 
t-- 
7-  20000 
o3 
A. RP105 blasts 
T 
2  4  6 
20000 
10000 
0 
day 
B. CD40 blasts 
T 
T 
T,  T 
2  4  6  8 
None 
--<>---  Anti-lgM(mAb) 
---O---  Anti-lgM(Rabbit) 
Anti-Fas 
Figure 2.  Inhibition of  RPl05 
and/or CD40 blasts with an anti- 
body  to  slgM  or  Fas  (time 
course).  RP105 and CD40 blasts 
were prepared as in Table 2, and 
cultured  with indicated  antibodies 
for  indicated  periods.  [3H]TdR 
was added  during the last 4 h  of 
the  culture.  Antibodies  were 
similar  to Fig.  1,  and used at  t{) 
p.g/nfl.  The  results  were  pre- 
sented as means -~  SD for tripli- 
cate  cultures.  The  results  with 
rabbit  anti-lgM  F(ab')2  were 
similar  to  those  with  the  intact 
antibody  with  respect  to  time 
course (data not shown). 
116  Regulation ofAnti-IgM-mediated Apoptosis by RP105 Table  3.  Celt  Cycle Arrest of RPl05 Blasts but Not CD40 
Blasts by Anti-IgM and Augmentation by Fc Receptor Coligation 
Cells in Cell Cycle Phase 
Cells  Ab  Go/Gi  S  Gz/M 
RP105 blasts 
CD40 blasts 
% 
None  73.9  19.2  6.9 
Control Ab  74.1  17.9  8.1 
Intact anti-IgM  94.3  3.0  2.7 
F(ab')2 anti-IgM  84.6  9.7  5.7 
Anti-Fas  69.7  23.7  6.6 
None  89.6  6.3  4.1 
Control Ab  86.6  6.1  7.4 
Intact anti-IgM  89.0  7.9  3.2 
F(ab')2 anti-IgM  74.9  22.4  2.7 
Anti-Fas  92.0  5.5  2.5 
RP105 or CD40 blast cells were incubated with the indicated antibod- 
ies for 24 h. Anti-CD44 Ab was used as a control Ab. Rabbit antibodies 
were used as intact and F(ab')2 antibodies.  DNA was stained with pro- 
pidium iodide and analyzed as described in Materials and Methods. Per- 
centages of  each cell cycle phase are shown. One representative result is 
presented from three independent experiments. 
most all RP105-positive B cells become blastic when cul- 
tured with anti-RP105 Ab (7, 8). As few as 5 X  103 B cells 
still  showed  a  significant  response  to  RP105  ligation 
(N30% of [3H]TdR uptake by 2  ￿  10  s B cells: Yamashita, 
Y., K. Miyake, and M. Kimoto, unpublished observation). 
The number of recovered R.P105  blasts  after 2-d culture 
was even larger than that of CD40 blasts (see the legend to 
Table 2).  Moreover, we  compared R.P105-  with  CD40- 
activated B  cells  in  terms  of cell surface markers  such  as 
CD23,  CD24,  IgD,  and  IgM,  and found no  differences. 
Thus, RP105 ligation results in activation/proliferation of a 
majority of, not a minority of B cells. It is more likely that 
RP105-dependent activation has an effect on the relation- 
ship  between antigen receptor signaling  and final cellular 
outcomes. Engagement of the B  cell antigen receptor ini- 
tiates a cascade of biochemical events including protein ty- 
rosine  kinase  activation,  phosphatidylinositol  hydrolysis, 
and calcium mobilization (for review see references 22 and 
23). Bifurcations are anticipated in these signaling events to 
lead to different cellular responses.  For example, Lyn ty- 
rosine kinase is differentially utilized in anti-IgM-induced 
cell cycle arrest and death. It is defined as a critical compo- 
nent for the former (24), but dispensable for the latter (25). 
In this regard, it is interesting to study early signaling events 
after slgM ligation in resting, CD40- and R.P105-activated 
B  cells. 
A.  B. 
RP105  blasts 
None  8.4% 
￿9  ,...,  ,  , 
Monoclonal]  o  / 
Anti-lgM 
,~,  ,L, J'~.  , 
Intact 
Anti-lgM 
F(ab')2 
Anti-lgM 
Anti-Fas 
CD40 beasts  RP105 blasts  CD40 blasts 
None  8.3%  9.3%] 
Anti-tgM  ~l 
Intact  ~  ~/ 
Anti-lgM  46.7%  19.5% 
Anti-lgM  19.o% 
,  ,  ,  i  ,  w..  [ %.  ,  , 
] 
control Ab  . Oo  tlO.1O/o,~  9.8%~  = , ",'.  , ;=',,  , 
,% 
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Figure  3.  Anti-IglVl induces 
apoptosis  in  RP105  but not in 
CD40  blasts. RP105  and CD40 
blasts were prepared  as in Table 
1,  and  cultured  with  the  indi- 
cated  antibodies  for 24  h.  Goat 
(A) or rabbit (B) antibodies were 
used  as  intact  and  F(ab')2 anti- 
IgM.  Cells were then fixed and 
DNA was stained  with propid- 
ium iodide.  Percentages  of sub- 
diploid DNA are shown in each 
panel. Figure  4.  RP105  blast cells show morphological features of apoptosis 
in response to anti-IgM. Wright Giemsa staining of RP105 blast cells that 
had been exposed to anti-IgM mAb for 12 h. (~') Apoptotic cells. 
The  present  study  demonstrates  that  anti-IgM-induced 
apoptosis of activated B  cells does not utilize the Fas mole- 
cule.  RP105  as  well  as  CD40  blasts  are  able  to  receive  a 
death signal via the Fas antigen  (Fig.  3).  However,  antigen 
receptor signaling probably does not result in Fas ligand ex- 
pression.  Our  finding  is consistent  with  a  recent  study  by 
Han et al.  (6) which showed that C57BL/6.1pr  mice remain 
fully susceptible  to  antigen-driven  B  cell  apoptosis  in  ger- 
minal  centers.  Moreover,  Rathmell  et  al.  (26)  demon- 
strated  that  elimination  of B  cells  recognizing  membrane- 
bound  autoantigen  occurs  normally despite  the  absence  of 
the Fas antigen.  Thus,  Fas-mediated apoptosis is dispensable 
for antigen-induced  B  cell death  and  some  other  category 
of molecules  may  be  involved.  T  cells  use  an  autocrine 
TNF/TNF  receptor system as well as the Fas-mediated apop- 
tosis for executing antigen-induced  cell death  (27,  28).  It is 
possible  that  antigen  receptor  signaling  leads  to  activation 
of a comparable system in certain B  cells. 
There  are  a  number  of functional  similarities  between 
CD40  and the more recently described RP105  antigen,  al- 
though the two proteins are structurally unrelated.  Whereas 
CD40 is a member of the TNF/nerve growth factor recep- 
tor family (for a review see reference 29),  RP105  is related 
to proteins with tandem repeats of a leucine-rich  motif (8). 
Ligation  of either molecule  with  rnAb  leads  to protection 
against irradiation-induced  apoptosis, massive proliferation, 
but  little  or  no  Ig secretion  (7,  29,  and  30).  Also,  B  cells 
from  immunodeficient  xid mice  fail  to  respond  to  either 
antibody  (7,  31).  The  majority  of normal  spleen  cells  that 
expresses  RP105  also  displays  CD40  and  blast  cells  pre- 
pared by stimulation  with either antibody express both an- 
tigens  (Yamashita,  Y.,  K.  Miyake,  and M.  Kimoto,  unpub- 
lished observations). Further study is needed to determine if 
the  same subsets of B  cells are responsive to stimulation  via 
either molecule.  However, we now demonstrate  that pop- 
ulations of actively dividing B lymphocytes are distinct,  de- 
pending  on which  of these molecules provided  the activa- 
tion  stimulus.  The  engagement  of  the  antigen  receptor 
induces  acceleration of cell cycle in those arising from liga- 
tion  of CD40,  whereas  growth  arrest  and  cell  death  in  B 
cell blasts results from RP105  ligation. 
The importance  of CD40  hgation  in  immune  responses 
is demonstrated  by CD40-deficient  mice  (32).  These mice 
show  impaired  Ig class  switching  and  germinal  center for- 
mation.  Proliferating cells in that site are thought  to be se- 
lected for survival/proliferation  if they display high affinity 
antigen  receptors,  and  simultaneously  receive  signals  via 
other  surface molecules such  as  CD40  (33).  Less is known 
about RP105,  but it is possible that it could also contribute 
to  cell  survival/proliferation  in  germinal  centers.  The  re- 
sults  reported  here  indicate  that  cells  rescued  only  on  the 
basis  of this  molecule  may be  destined  to  die  when  their 
antigen receptors are utilized.  Recent studies (4-6) demon- 
strated  that some B  cells  in  germinal  centers  are poised  to 
die  in  response  to  antigen.  Germinal  centers  are  sites  for 
antigen-induced  deletion  of B  cells as well  as for survival/ 
proliferation.  It  is  difficult  to  imagine  how  CD40  alone 
governs these  quite  different  processes.  Indeed,  a  blocking 
antibody specific for the CD40  ligand did not abrogate an- 
tigen-driven  B  cell  death  in  germinal  centers  (6).  Galibert 
et al.  (34)  showed that dual triggering of CD40  and slg in- 
duces  B  cells  to  express  a  germinal  center  phenotype,  in- 
cluding  high  susceptibility  to  spontaneous  apoptosis  that 
becomes apparent after 6-d stimulation.  In our culture  sys- 
tem, it was difficult to study blast cells after 6-d culture,  be- 
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Figure  5.  The  expression of 
Fas  antigen increases on  CD40 
but  not  on  RP105  blasts. Puri- 
fied B cells from spleen, RP105 
blasts,  and  CD40  blasts were 
stained with Jo2  (anti-Fas mAb) 
followed by protein A-FITC. 
118  Regulation ofAnti-IgM-mediated Apoptosis by RP105 Table 4.  Fas Antigen Is Not Required  for B Cell Death by 
Antigen Receptor Ligation 
Apoptotic cells 
Exp.  Ab  R.P105 blasts  CD40 blasts 
% 
None  16.3  23.9 
Monoclonal anti-IgM  43.1  23.6 
Anti-Fas  15.8  27.8 
None  23.8  19.5 
Control Ab  31.4  28.7 
Monoclonal anti-IgM  48.0  22.9 
Intact anti-IgM  43.9  23.8 
Anti-Fas  22.4  24.8 
KP105  or CD40 blast ceils from MRL-Ipr/Ipr mice were incubated 
with the indicated antibodies for 24 h. Anti-CD45/B220  was used as a 
control Ab. Rabbit  antibodies were used as intact anti-IgM Ab. The 
content  of DNA was determined by staining with propidium iodide 
and analyzed on a FACScan  |  Percentages ofceUs with subdiploid DNA 
are showI'L 
cause only a small number of cells remained to grow (Fig. 
2).  Galibert  et  al.  (34)  used  a  fibroblast  that  expresses  the 
human Fc receptor and CD40 ligand.  It is worth trying to 
stimulate B  cells with anti-RP105 immobilized on a fibro- 
blast for a longer period,  and to see their susceptibilities  to 
slgM-induced apoptosis. 
The Fc',/RIIB has been shown to abort signaling through 
the  B  cell  antigen  receptor  when  it  is  engaged  together 
with  sIgM  (35).  Indeed,  F(ab')2 fragments,  but  not intact 
anti-IgM, were capable of activating splenic B  cells  (Table 
1)  or influencing the  cell  cycle of CD40 blasts  (Table  3). 
Therefore, it was expected that coligation of the Fc~/RIIB 
might prevent anti-IgM-induced growth arrest and apop- 
tosis oftLP105 blasts.  However, this was not the case, and 
intact anti-IgM was required  for optimal inhibition.  Anti- 
Fc~/tLIIB itself did not induce cell cycle arrest or cell death, 
and  did  not  augment  the  effects  of anti-IgM  (Yamashita, 
Y., K. Miyake, and M. Kimoto, unpublished observations). 
Thus,  responses did not result from independent  signaling 
through the Fc~tLIIB but from coligation with slgM. A ty- 
rosine phosphatase,  PTP1C/HCP/SH-PTP1,  has been re- 
cently implicated in negative regulation of antigen receptor 
signaling by Fc~/tLIIB (36, 37). Tyrosine phosphorylation of 
Fc~IklIB  recruits  PTP1C/HCP/SH-PTP1  to  the  antigen 
receptor complex, and allows for dephosphorylaton of ap- 
propriate substrates.  Similarly,  PTP1C/HCP/SH-PTP1  or 
other signaling molecules may be recruited and modulate a 
slgM-mediated signal that results in growth arrest and apop- 
tosis. 
T  cells  use antigen-induced apoptosis for deletion of ex- 
cessive T  cells that have been previously activated (For re- 
views see references 2 and 3). Similar cell death must occur 
in antibody responses, and the anti-IgM-induced cell death 
described here may represent such a mechanism.  In this re- 
gard,  Fc~RIIB coligation has been proposed  as  a  mecha- 
nism for immune complex-dependent feedback inhibition 
of antibody  responses  (38).  However,  previous  investiga- 
tors have studied only resting, and not actively proliferating 
B  cells.  We have now demonstrated a circumstance where 
immune  complexes  can  effectively  induce  growth  arrest 
and deletion of activated B cells. 
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